Tri Locum Partners as of March 31, 2023
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 47 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Regeneron Pharmaceuticals (REGN) | 10.9 | $36M | 43k | 821.67 | |
West Pharmaceutical Services (WST) | 7.1 | $23M | 67k | 346.47 | |
Abbott Laboratories (ABT) | 5.4 | $18M | 175k | 101.26 | |
Tandem Diabetes Care Com New (TNDM) | 5.2 | $17M | 417k | 40.61 | |
Eli Lilly & Co. (LLY) | 4.6 | $15M | 44k | 343.42 | |
Catalent (CTLT) | 4.5 | $15M | 225k | 65.71 | |
Illumina (ILMN) | 4.4 | $15M | 63k | 232.55 | |
Ark Etf Tr Unit (ARKK) | 4.3 | $14M | 350k | 40.34 | |
Sarepta Therapeutics (SRPT) | 3.7 | $12M | 89k | 137.83 | |
Avadel Pharmaceuticals Sponsored Adr (AVDL) | 3.7 | $12M | 1.3M | 9.16 | |
Merck & Co (MRK) | 3.7 | $12M | 114k | 106.39 | |
Axsome Therapeutics (AXSM) | 2.8 | $9.2M | 149k | 61.68 | |
Thermo Fisher Scientific (TMO) | 2.8 | $9.2M | 16k | 576.37 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.7 | $9.0M | 1.0M | 8.85 | |
Evolent Health Cl A (EVH) | 2.6 | $8.7M | 268k | 32.45 | |
Xenon Pharmaceuticals (XENE) | 2.4 | $7.9M | 222k | 35.79 | |
Abbvie (ABBV) | 2.4 | $7.8M | 49k | 159.37 | |
BioMarin Pharmaceutical (BMRN) | 2.3 | $7.4M | 76k | 97.24 | |
Stevanato Group S P A Ord Shs (STVN) | 2.2 | $7.2M | 278k | 25.90 | |
Reata Pharmaceuticals Cl A | 1.9 | $6.1M | 67k | 90.92 | |
Guardant Health (GH) | 1.8 | $6.0M | 255k | 23.44 | |
Ventyx Biosciences (VTYX) | 1.6 | $5.1M | 153k | 33.50 | |
Apellis Pharmaceuticals (APLS) | 1.5 | $5.1M | 77k | 65.96 | |
Uniqure Nv SHS (QURE) | 1.4 | $4.6M | 227k | 20.14 | |
Inspire Med Sys (INSP) | 1.2 | $4.1M | 18k | 234.07 | |
Astria Therapeutics (ATXS) | 1.1 | $3.7M | 275k | 13.30 | |
Akero Therapeutics (AKRO) | 1.0 | $3.4M | 89k | 38.26 | |
X4 Pharmaceuticals (XFOR) | 1.0 | $3.4M | 3.9M | 0.87 | |
Madrigal Pharmaceuticals (MDGL) | 1.0 | $3.4M | 14k | 242.26 | |
Viking Therapeutics (VKTX) | 1.0 | $3.3M | 200k | 16.65 | |
Beam Therapeutics (BEAM) | 1.0 | $3.3M | 107k | 30.62 | |
Protagonist Therapeutics (PTGX) | 0.9 | $3.1M | 134k | 23.00 | |
Prometheus Biosciences | 0.9 | $3.1M | 29k | 107.32 | |
Iveric Bio | 0.8 | $2.6M | 107k | 24.33 | |
Roivant Sciences SHS (ROIV) | 0.8 | $2.5M | 345k | 7.38 | |
89bio (ETNB) | 0.7 | $2.4M | 157k | 15.23 | |
Altimmune Com New (ALT) | 0.7 | $2.2M | 529k | 4.22 | |
Praxis Precision Medicines I | 0.6 | $2.0M | 2.5M | 0.81 | |
Verona Pharma Sponsored Ads (VRNA) | 0.6 | $2.0M | 98k | 20.08 | |
Evolus (EOLS) | 0.4 | $1.4M | 160k | 8.46 | |
Femasys (FEMY) | 0.0 | $137k | 127k | 1.08 | |
Antero Midstream Corp antero midstream (AM) | 0.0 | $117k | 11k | 10.49 | |
B2gold Corp (BTG) | 0.0 | $75k | 19k | 3.94 | |
Paramount Group Inc reit (PGRE) | 0.0 | $68k | 15k | 4.56 | |
Equitrans Midstream Corp (ETRN) | 0.0 | $59k | 10k | 5.78 | |
Southwestern Energy Company (SWN) | 0.0 | $52k | 10k | 5.00 | |
Uniti Group Inc Com reit (UNIT) | 0.0 | $40k | 11k | 3.55 |